{
    "url": "https://en.wikipedia.org/wiki/List_of_largest_pharmaceutical_settlements",
    "title": "List of largest pharmaceutical settlements",
    "header": [
        [
            "Year",
            []
        ],
        [
            "Company",
            []
        ],
        [
            "Settlement",
            []
        ],
        [
            "Violation ( s )",
            []
        ],
        [
            "Product ( s )",
            []
        ],
        [
            "Laws allegedly violated ( if applicable )",
            []
        ]
    ],
    "data": [
        [
            [
                "2012",
                []
            ],
            [
                "GlaxoSmithKline",
                [
                    "/wiki/GlaxoSmithKline"
                ],
                [
                    {
                        "entity id": "Q212322",
                        "label": "GlaxoSmithKline"
                    }
                ]
            ],
            [
                "$ 3 billion ( $ 1B criminal , $ 2B civil )",
                []
            ],
            [
                "Criminal : Off-label promotion , failure to disclose safety data . Civil : paying kickbacks to physicians , making false and misleading statements concerning the safety of Avandia , reporting false best prices and underpaying rebates owed under the Medicaid Drug Rebate Program",
                [
                    "/wiki/Medicaid_Drug_Rebate_Program"
                ],
                [
                    {
                        "entity id": "Q6806243",
                        "label": "Medicaid Drug Rebate Program"
                    }
                ]
            ],
            [
                "Avandia ( not providing safety data ) , Wellbutrin , Paxil ( promotion of paediatric use ) , Advair , Lamictal , Zofran , Imitrex , Lotronex , Flovent , Valtrex ;",
                [
                    "/wiki/Rosiglitazone",
                    "/wiki/Bupropion",
                    "/wiki/Paroxetine",
                    "/wiki/Advair",
                    "/wiki/Lamictal",
                    "/wiki/Zofran",
                    "/wiki/Imitrex",
                    "/wiki/Lotronex",
                    "/wiki/Flovent",
                    "/wiki/Valtrex"
                ],
                [
                    {
                        "entity id": "Q424771",
                        "label": "rosiglitazone"
                    },
                    {
                        "entity id": "Q834280",
                        "label": "bupropion"
                    },
                    {
                        "entity id": "Q408471",
                        "label": "paroxetine"
                    },
                    {
                        "entity id": "Q581334",
                        "label": "fluticasone/salmeterol"
                    },
                    {
                        "entity id": "Q410346",
                        "label": "lamotrigine"
                    },
                    {
                        "entity id": "Q47522352",
                        "label": "Zofran"
                    },
                    {
                        "entity id": "Q48828069",
                        "label": "Imitrex"
                    },
                    {
                        "entity id": "Q47521792",
                        "label": "Lotronex"
                    },
                    {
                        "entity id": "Q47521620",
                        "label": "Flovent"
                    },
                    {
                        "entity id": "Q47522261",
                        "label": "Valtrex"
                    }
                ]
            ],
            [
                "False Claims Act / FDCA",
                [
                    "/wiki/False_Claims_Act",
                    "/wiki/Federal_Food,_Drug,_and_Cosmetic_Act"
                ],
                [
                    {
                        "entity id": "Q3064815",
                        "label": "False Claims Act"
                    },
                    {
                        "entity id": "Q3067874",
                        "label": "Federal Food, Drug, and Cosmetic Act"
                    }
                ]
            ]
        ],
        [
            [
                "2009",
                []
            ],
            [
                "Pfizer",
                [
                    "/wiki/Pfizer"
                ],
                [
                    {
                        "entity id": "Q206921",
                        "label": "Pfizer"
                    }
                ]
            ],
            [
                "$ 2.3 billion",
                []
            ],
            [
                "Off-label promotion/ kickbacks",
                [
                    "/wiki/Kickback_(bribery)"
                ],
                [
                    {}
                ]
            ],
            [
                "Bextra / Geodon / Zyvox / Lyrica",
                [
                    "/wiki/Valdecoxib",
                    "/wiki/Ziprasidone",
                    "/wiki/Linezolid",
                    "/wiki/Pregabalin"
                ],
                [
                    {
                        "entity id": "Q347613",
                        "label": "valdecoxib"
                    },
                    {
                        "entity id": "Q205517",
                        "label": "ziprasidone"
                    },
                    {
                        "entity id": "Q411377",
                        "label": "linezolid"
                    },
                    {
                        "entity id": "Q412174",
                        "label": "pregabalin"
                    }
                ]
            ],
            [
                "False Claims Act/FDCA",
                []
            ]
        ],
        [
            [
                "2013",
                []
            ],
            [
                "Johnson & Johnson",
                [
                    "/wiki/Johnson_&_Johnson"
                ],
                [
                    {
                        "entity id": "Q333718",
                        "label": "Johnson & Johnson"
                    }
                ]
            ],
            [
                "$ 2.2 billion",
                []
            ],
            [
                "Off-label promotion/ kickbacks",
                [
                    "/wiki/Kickback_(bribery)"
                ],
                [
                    {}
                ]
            ],
            [
                "Risperdal / Invega / Nesiritide",
                [
                    "/wiki/Risperidone",
                    "/wiki/Paliperidone",
                    "/wiki/Nesiritide"
                ],
                [
                    {
                        "entity id": "Q412443",
                        "label": "risperidone"
                    },
                    {
                        "entity id": "Q423292",
                        "label": "paliperidone"
                    },
                    {
                        "entity id": "Q6997373",
                        "label": "nesiritide"
                    }
                ]
            ],
            [
                "False Claims Act/FDCA",
                []
            ]
        ],
        [
            [
                "2012",
                []
            ],
            [
                "Abbott Laboratories",
                [
                    "/wiki/Abbott_Laboratories"
                ],
                [
                    {
                        "entity id": "Q306764",
                        "label": "Abbott Laboratories"
                    }
                ]
            ],
            [
                "$ 1.5 billion",
                []
            ],
            [
                "Off-label promotion",
                []
            ],
            [
                "Depakote",
                [
                    "/wiki/Valproic_acid"
                ],
                [
                    {
                        "entity id": "Q240642",
                        "label": "valproic acid"
                    }
                ]
            ],
            [
                "False Claims Act/FDCA",
                []
            ]
        ],
        [
            [
                "2009",
                []
            ],
            [
                "Eli Lilly",
                [
                    "/wiki/Eli_Lilly_and_Company"
                ],
                [
                    {
                        "entity id": "Q632240",
                        "label": "Eli Lilly and Company"
                    }
                ]
            ],
            [
                "$ 1.4 billion",
                []
            ],
            [
                "Off-label promotion",
                []
            ],
            [
                "Zyprexa",
                [
                    "/wiki/Olanzapine"
                ],
                [
                    {
                        "entity id": "Q201872",
                        "label": "olanzapine"
                    }
                ]
            ],
            [
                "False Claims Act/FDCA",
                []
            ]
        ],
        [
            [
                "2001",
                []
            ],
            [
                "TAP Pharmaceutical Products",
                [
                    "/wiki/TAP_Pharmaceutical_Products"
                ],
                [
                    {
                        "entity id": "Q7669338",
                        "label": "TAP Pharmaceutical Products"
                    }
                ]
            ],
            [
                "$ 875 million",
                []
            ],
            [
                "Medicare fraud /kickbacks",
                [
                    "/wiki/Medicare_fraud"
                ],
                [
                    {
                        "entity id": "Q6806650",
                        "label": "Medicare fraud"
                    }
                ]
            ],
            [
                "Lupron",
                [
                    "/wiki/Leuprorelin"
                ],
                [
                    {
                        "entity id": "Q907160",
                        "label": "leuprolide"
                    }
                ]
            ],
            [
                "False Claims Act/ Prescription Drug Marketing Act",
                [
                    "/wiki/Prescription_Drug_Marketing_Act"
                ],
                [
                    {
                        "entity id": "Q7240890",
                        "label": "Prescription Drug Marketing Act"
                    }
                ]
            ]
        ],
        [
            [
                "2012",
                []
            ],
            [
                "Amgen",
                [
                    "/wiki/Amgen"
                ],
                [
                    {
                        "entity id": "Q470517",
                        "label": "Amgen"
                    }
                ]
            ],
            [
                "$ 762 million",
                []
            ],
            [
                "Off-label promotion/kickbacks",
                []
            ],
            [
                "Aranesp",
                [
                    "/wiki/Aranesp"
                ],
                [
                    {
                        "entity id": "Q29004837",
                        "label": "Aranesp"
                    }
                ]
            ],
            [
                "False Claims Act/FDCA",
                []
            ]
        ],
        [
            [
                "2010",
                []
            ],
            [
                "GlaxoSmithKline",
                []
            ],
            [
                "$ 750 million",
                []
            ],
            [
                "Poor manufacturing practices",
                []
            ],
            [
                "Kytril / Bactroban / Paxil CR / Avandamet",
                [
                    "/wiki/Granisetron",
                    "/wiki/Mupirocin",
                    "/wiki/Paroxetine",
                    "/wiki/Metformin"
                ],
                [
                    {
                        "entity id": "Q596708",
                        "label": "granisetron"
                    },
                    {
                        "entity id": "Q413578",
                        "label": "mupirocin"
                    },
                    {
                        "entity id": "Q408471",
                        "label": "paroxetine"
                    },
                    {
                        "entity id": "Q19484",
                        "label": "metformin"
                    }
                ]
            ],
            [
                "False Claims Act/FDCA",
                []
            ]
        ],
        [
            [
                "2005",
                []
            ],
            [
                "Serono",
                [
                    "/wiki/Serono"
                ],
                [
                    {
                        "entity id": "Q669903",
                        "label": "Serono"
                    }
                ]
            ],
            [
                "$ 704 million",
                []
            ],
            [
                "Off-label promotion/ kickbacks/ monopoly practices",
                [
                    "/wiki/Monopoly"
                ],
                [
                    {
                        "entity id": "Q17243",
                        "label": "Monopoly"
                    }
                ]
            ],
            [
                "Serostim",
                [
                    "/wiki/Serostim"
                ],
                [
                    {
                        "entity id": "Q7455039",
                        "label": "Serostim"
                    }
                ]
            ],
            [
                "False Claims Act",
                []
            ]
        ],
        [
            [
                "2008",
                []
            ],
            [
                "Merck",
                [
                    "/wiki/Merck_&_Co."
                ],
                [
                    {
                        "entity id": "Q247489",
                        "label": "Merck & Co."
                    }
                ]
            ],
            [
                "$ 650 million",
                []
            ],
            [
                "Medicare fraud/kickbacks",
                []
            ],
            [
                "Zocor / Vioxx / Pepsid",
                [
                    "/wiki/Simvastatin",
                    "/wiki/Rofecoxib",
                    "/wiki/Famotidine"
                ],
                [
                    {
                        "entity id": "Q670131",
                        "label": "simvastatin"
                    },
                    {
                        "entity id": "Q411412",
                        "label": "rofecoxib"
                    },
                    {
                        "entity id": "Q411159",
                        "label": "famotidine"
                    }
                ]
            ],
            [
                "False Claims Act/ Medicaid Rebate Statute",
                []
            ]
        ],
        [
            [
                "2007",
                []
            ],
            [
                "Purdue Pharma",
                [
                    "/wiki/Purdue_Pharma"
                ],
                [
                    {
                        "entity id": "Q7260981",
                        "label": "Purdue Pharma"
                    }
                ]
            ],
            [
                "$ 601 million",
                []
            ],
            [
                "Off-label promotion",
                []
            ],
            [
                "Oxycontin",
                [
                    "/wiki/Oxycontin"
                ],
                [
                    {
                        "entity id": "Q407535",
                        "label": "oxycodone"
                    }
                ]
            ],
            [
                "False Claims Act",
                []
            ]
        ],
        [
            [
                "2010",
                []
            ],
            [
                "Allergan",
                [
                    "/wiki/Allergan"
                ],
                [
                    {
                        "entity id": "Q413486",
                        "label": "diphenhydramine"
                    }
                ]
            ],
            [
                "$ 600 million",
                []
            ],
            [
                "Off-label promotion",
                []
            ],
            [
                "Botox",
                [
                    "/wiki/Botulinum_toxin"
                ],
                [
                    {
                        "entity id": "Q29957827",
                        "label": "Botulinum Toxin"
                    }
                ]
            ],
            [
                "False Claims Act/FDCA",
                []
            ]
        ],
        [
            [
                "2010",
                []
            ],
            [
                "AstraZeneca",
                [
                    "/wiki/AstraZeneca"
                ],
                [
                    {
                        "entity id": "Q731938",
                        "label": "AstraZeneca"
                    }
                ]
            ],
            [
                "$ 520 million",
                []
            ],
            [
                "Off-label promotion/kickbacks",
                []
            ],
            [
                "Seroquel",
                [
                    "/wiki/Quetiapine"
                ],
                [
                    {
                        "entity id": "Q408535",
                        "label": "quetiapine"
                    }
                ]
            ],
            [
                "False Claims Act",
                []
            ]
        ],
        [
            [
                "2007",
                []
            ],
            [
                "Bristol-Myers Squibb",
                [
                    "/wiki/Bristol-Myers_Squibb"
                ],
                [
                    {
                        "entity id": "Q266423",
                        "label": "Bristol-Myers Squibb"
                    }
                ]
            ],
            [
                "$ 515 million",
                []
            ],
            [
                "Off-label promotion/ kickbacks/Medicare fraud",
                []
            ],
            [
                "Abilify / Serzone",
                [
                    "/wiki/Aripiprazole",
                    "/wiki/Nefazodone"
                ],
                [
                    {
                        "entity id": "Q411188",
                        "label": "aripiprazole"
                    },
                    {
                        "entity id": "Q416632",
                        "label": "nefazodone"
                    }
                ]
            ],
            [
                "False Claims Act/FDCA",
                []
            ]
        ],
        [
            [
                "2002",
                []
            ],
            [
                "Schering-Plough",
                [
                    "/wiki/Schering-Plough"
                ],
                [
                    {
                        "entity id": "Q249723",
                        "label": "Schering-Plough"
                    }
                ]
            ],
            [
                "$ 500 million",
                []
            ],
            [
                "Poor manufacturing practices",
                []
            ],
            [
                "Claritin",
                [
                    "/wiki/Loratadine"
                ],
                [
                    {
                        "entity id": "Q424049",
                        "label": "loratadine"
                    }
                ]
            ],
            [
                "FDA Current Good Manufacturing Practices",
                [
                    "/wiki/Food_and_Drug_Administration",
                    "/wiki/Good_manufacturing_practice"
                ],
                [
                    {
                        "entity id": "Q204711",
                        "label": "Food and Drug Administration"
                    },
                    {
                        "entity id": "Q1292017",
                        "label": "Good manufacturing practice"
                    }
                ]
            ]
        ],
        [
            [
                "2006",
                []
            ],
            [
                "Mylan",
                [
                    "/wiki/Mylan"
                ],
                [
                    {
                        "entity id": "Q899010",
                        "label": "Mylan"
                    }
                ]
            ],
            [
                "$ 465 million",
                []
            ],
            [
                "Misclassification under the Medicaid Drug Rebate Program",
                [
                    "/wiki/Medicaid_Drug_Rebate_Program"
                ],
                [
                    {
                        "entity id": "Q6806243",
                        "label": "Medicaid Drug Rebate Program"
                    }
                ]
            ],
            [
                "EpiPen ( epinephrine )",
                [
                    "/wiki/EpiPen",
                    "/wiki/Epinephrine"
                ],
                [
                    {
                        "entity id": "Q2736787",
                        "label": "epinephrine autoinjector"
                    },
                    {
                        "entity id": "Q132621",
                        "label": "epinephrine"
                    }
                ]
            ],
            [
                "False Claims Act",
                [
                    "/wiki/False_Claims_Act"
                ],
                [
                    {
                        "entity id": "Q3064815",
                        "label": "False Claims Act"
                    }
                ]
            ]
        ],
        [
            [
                "2006",
                []
            ],
            [
                "Schering-Plough",
                []
            ],
            [
                "$ 435 million",
                []
            ],
            [
                "Off-label promotion/ kickbacks/Medicare fraud",
                []
            ],
            [
                "Temodar / Intron A / K-Dur / Claritin RediTabs",
                [
                    "/wiki/Temozolomide",
                    "/wiki/Interferon_alfa-2b",
                    "/wiki/Potassium_chloride",
                    "/wiki/Loratadine"
                ],
                [
                    {
                        "entity id": "Q425088",
                        "label": "Temozolomide"
                    },
                    {
                        "entity id": "Q4391540",
                        "label": "interferon Alfa-2b, Recombinant"
                    },
                    {
                        "entity id": "Q28453483",
                        "label": "potassium chloride"
                    },
                    {
                        "entity id": "Q424049",
                        "label": "loratadine"
                    }
                ]
            ],
            [
                "False Claims Act/FDCA",
                []
            ]
        ],
        [
            [
                "2004",
                []
            ],
            [
                "Pfizer",
                []
            ],
            [
                "$ 430 million",
                []
            ],
            [
                "Off-label promotion",
                []
            ],
            [
                "Neurontin",
                [
                    "/wiki/Gabapentin"
                ],
                [
                    {
                        "entity id": "Q410352",
                        "label": "gabapentin"
                    }
                ]
            ],
            [
                "False Claims Act/FDCA",
                []
            ]
        ],
        [
            [
                "2008",
                []
            ],
            [
                "Cephalon",
                [
                    "/wiki/Cephalon"
                ],
                [
                    {
                        "entity id": "Q10994170",
                        "label": "cephalon"
                    }
                ]
            ],
            [
                "$ 425 million",
                []
            ],
            [
                "Off-label promotion",
                []
            ],
            [
                "Actiq / Gabitril / Provigil",
                [
                    "/wiki/Actiq",
                    "/wiki/Tiagabine",
                    "/wiki/Modafinil"
                ],
                [
                    {
                        "entity id": "Q2898632",
                        "label": "Actiq"
                    },
                    {
                        "entity id": "Q907219",
                        "label": "tiagabine"
                    },
                    {
                        "entity id": "Q410441",
                        "label": "modafinil"
                    }
                ]
            ],
            [
                "False Claims Act/FDCA",
                []
            ]
        ],
        [
            [
                "2010",
                []
            ],
            [
                "Novartis",
                [
                    "/wiki/Novartis"
                ],
                [
                    {
                        "entity id": "Q507154",
                        "label": "Novartis"
                    }
                ]
            ],
            [
                "$ 423 million",
                []
            ],
            [
                "Off-label promotion/kickbacks",
                []
            ],
            [
                "Trileptal",
                [
                    "/wiki/Oxcarbazepine"
                ],
                [
                    {
                        "entity id": "Q176301",
                        "label": "oxcarbazepine"
                    }
                ]
            ],
            [
                "False Claims Act/FDCA",
                []
            ]
        ]
    ],
    "section_title": "",
    "section_text": "The following is a list of the 20 largest settlements reached between the United States Department of Justice and pharmaceutical companies from 1991 to 2012 , ordered by the size of the total settlement . The settlement amount includes both the civil ( False Claims Act ) settlement and criminal fine . Glaxo 's $ 3 billion settlement included the largest civil , False Claims Act settlement on record , [ 1 ] and Pfizer \u2019 s $ 2.3 billion settlement including a record-breaking $ 1.3 billion criminal fine . [ 2 ] Legal claims against the pharmaceutical industry have varied widely over the past two decades , including Medicare and Medicaid fraud , off-label promotion , and inadequate manufacturing practices . [ 3 ] [ 4 ] With respect to off-label promotion , specifically , a federal court recognized off-label promotion as a violation of the False Claims Act for the first time in Franklin v. Parke-Davis , leading to a $ 430 million settlement . [ 5 ]",
    "uid": "List_of_largest_pharmaceutical_settlements_0",
    "intro": "The following is a list of the 20 largest settlements reached between the United States Department of Justice and pharmaceutical companies from 1991 to 2012, ordered by the size of the total settlement. The settlement amount includes both the civil (False Claims Act) settlement and criminal fine. Glaxo's $3 billion settlement included the largest civil, False Claims Act settlement on record, and Pfizers $2.3 billion settlement including a record-breaking $1.3 billion criminal fine. Legal claims against the pharmaceutical industry have varied widely over the past two decades, including Medicare and Medicaid fraud, off-label promotion, and inadequate manufacturing practices. With respect to off-label promotion, specifically, a federal court recognized off-label promotion as a violation of the False Claims Act for the first time in Franklin v. Parke-Davis, leading to a $430 million settlement."
}